Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Lewis

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The Science of the Total Environment|December 1, 2020
Combining zinc desorption with EXAFS speciation analysis to understand Zn mobility in mining and smelting affected soils in Minas Gerais, BrazilGuilherme Lopes, Wei Li, Matthew G Siebecker, et al.
Headache|May 15, 2002
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled studyPaul Winner, Donald Lewis, W Hester Visser, et al.
Clinical Pediatrics|February 13, 2010
Identifying the "tipping point" age for overweight pediatric patientsJohn W Harrington, Vu Q Nguyen, James F Paulson, et al.
Headache|March 15, 2011
Abdominal migraine: an under-diagnosed cause of recurrent abdominal pain in childrenLaura Carson, Donald Lewis, Marc Tsou, et al.
Headache|September 28, 2004
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studiesW Hester Visser, Paul Winner, Kim Strohmaier, et al.
Clinical Pediatrics|May 8, 2009
Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosingStan L Block, Douglas Kelsey, Daniel Coury, et al.
Vaccine|October 18, 2017
Validation of administrative data to estimate vaccine impact: Audit of the Fiji hospital admissions electronic database, 2007-2011 & 2014-2015Rita Reyburn, Devina Nand, Cattram Nguyen, et al.
Pediatrics|March 4, 2009
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of ageDonald Lewis, Paul Winner, Joel Saper, et al.
Headache|July 30, 2011
Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescentsSusan A McDonald, Andrew D Hershey, Eric Pearlman, et al.
Pediatrics|May 16, 2012
Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraineFrederick J Derosier, Donald Lewis, Andrew D Hershey, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The Science of the Total Environment|December 1, 2020
Combining zinc desorption with EXAFS speciation analysis to understand Zn mobility in mining and smelting affected soils in Minas Gerais, BrazilGuilherme Lopes, Wei Li, Matthew G Siebecker, et al.
Headache|May 15, 2002
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled studyPaul Winner, Donald Lewis, W Hester Visser, et al.
Clinical Pediatrics|February 13, 2010
Identifying the "tipping point" age for overweight pediatric patientsJohn W Harrington, Vu Q Nguyen, James F Paulson, et al.
Headache|March 15, 2011
Abdominal migraine: an under-diagnosed cause of recurrent abdominal pain in childrenLaura Carson, Donald Lewis, Marc Tsou, et al.
Headache|September 28, 2004
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studiesW Hester Visser, Paul Winner, Kim Strohmaier, et al.
Clinical Pediatrics|May 8, 2009
Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosingStan L Block, Douglas Kelsey, Daniel Coury, et al.
Vaccine|October 18, 2017
Validation of administrative data to estimate vaccine impact: Audit of the Fiji hospital admissions electronic database, 2007-2011 & 2014-2015Rita Reyburn, Devina Nand, Cattram Nguyen, et al.
Pediatrics|March 4, 2009
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of ageDonald Lewis, Paul Winner, Joel Saper, et al.
Headache|July 30, 2011
Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescentsSusan A McDonald, Andrew D Hershey, Eric Pearlman, et al.
Pediatrics|May 16, 2012
Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraineFrederick J Derosier, Donald Lewis, Andrew D Hershey, et al.
Pageof 3